Value Aligned Research Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80M Sell
184,700
-21,900
-11% -$6.65M 0.2% 63
2026
Q1
$44.1M Buy
206,600
+59,200
+40% +$13.2M 0.21% 55
2025
Q4
$25.2M Buy
147,400
+100
+0.1% +$15.6K 0.25% 51
2025
Q3
$19.7M Buy
147,300
+1,300
+0.9% +$138K 0.24% 50
2025
Q2
$14.2M Buy
146,000
+129,800
+801% +$10.3M 0.3% 46
2025
Q1
$1.18M Buy
+16,200
New +$1.28M 0.09% 41
2024
Q3
Sell
-2,000
Closed -$17.4K 26
2024
Q2
$17.4K Buy
+2,000
New +$192K ﹤0.01% 26

Other funds holding LRCX

Value Aligned Research Advisors's LRCX Position: Q2 2026 in Review

Value Aligned Research Advisors reduced its Lam Research (LRCX) stake by 89% in Q2 2026, selling an estimated $297M and leaving 121,597 shares worth $52.7M. The position accounts for 0.13% of the portfolio, ranked #76.

Value Aligned Research Advisors first reported a position in LRCX in Q4 2022 and has held it in 14 quarters since. The position peaked at $235M in Q1 2026. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Value Aligned Research Advisors held 121,597 shares of Lam Research worth $52.7M as of Q2 2026.
  • Value Aligned Research Advisors sold 978,959 Lam Research shares in Q2 2026, an estimated $297M.
  • Lam Research made up 0.13% of Value Aligned Research Advisors's portfolio in Q2 2026, its #76 holding.
  • Value Aligned Research Advisors first reported a position in Lam Research in Q4 2022 and has held it in 14 quarters since.
  • Value Aligned Research Advisors's Lam Research position peaked at $235M in Q1 2026.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Value Aligned Research Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.